BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Fatiha Nassir, Jamal Ibdah. Role of Mitochondria in Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2014; 15(5): 8713 doi: 10.3390/ijms15058713
2
Fei Ji, Yao Liang, Shunjun Fu, Dubo Chen, XiuQin Cai, Shaoqiang Li, Baogang Peng, Lijian Liang, Yunpeng Hua. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomyHPB 2017; 19(8): 695 doi: 10.1016/j.hpb.2017.04.008
3
Luis Solorio, Hanping Wu, Christopher Hernandez, Mihika Gangolli, Agata A Exner. Ultrasound-guided intratumoral delivery of doxorubicin fromin situforming implants in a hepatocellular carcinoma modelTherapeutic Delivery 2016; 7(4): 201 doi: 10.4155/tde-2015-0008
4
Filomena Morisco, Maria Guarino, Maria R. Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani. Metabolic disorders across hepatocellular carcinoma in ItalyLiver International 2018; 38(11): 2028 doi: 10.1111/liv.13877
5
Chiara Saponaro, Melania Gaggini, Fabrizia Carli, Amalia Gastaldelli. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic HomeostasisNutrients 2015; 7(11): 9453 doi: 10.3390/nu7115475
6
Julius Dongsogo, Christopher Larbie. Association of metabolic syndrome with the risk of developing liver disease in chronic hepatitis B patientsAfrican Journal of Biochemistry Research 2019; 13(2): 23 doi: 10.5897/AJBR2017.0956
7
Talya L. Dayton, Vasilena Gocheva, Kathryn M. Miller, William J. Israelsen, Arjun Bhutkar, Clary B. Clish, Shawn M. Davidson, Alba Luengo, Roderick T. Bronson, Tyler Jacks, Matthew G. Vander Heiden. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinomaGenes & Development 2016; 30(9): 1020 doi: 10.1101/gad.278549.116
8
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver diseaseQJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
9
I. Glory Josephine, K. Punnagai. In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) CellsBiomedical and Pharmacology Journal 2019; 12(2): 901 doi: 10.13005/bpj/1715
10
Stephanie Mueller, Jérémy Huard, Katharina Waldow, Xiaoyun Huang, Lorenza A D'Alessandro, Sebastian Bohl, Kathleen Börner, Dirk Grimm, Steffen Klamt, Ursula Klingmüller, Marcel Schilling. T160‐phosphorylated CDK 2 defines threshold for HGF ‐dependent proliferation in primary hepatocytes Molecular Systems Biology 2015; 11(3): 795 doi: 10.15252/msb.20156032
11
Hiroyasu Sakai, Yohei Shirakami, Masahito Shimizu. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsWorld Journal of Gastroenterology 2016; 22(1): 394-406 doi: 10.3748/wjg.v22.i1.394
12
Barbara Schellhaas. Diagnose geht auch ohne BiopsieIm Focus Onkologie 2018; 21(4): 65 doi: 10.1007/s15015-018-3911-4
13
Vivian Klungboonkrong, Dola Das, Gordon McLennan. Molecular Mechanisms and Targets of Therapy for Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2017; 28(7): 949 doi: 10.1016/j.jvir.2017.03.002
14
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho. Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver DiseaseEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/4956079
15
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
16
Allison J. Kasmari, Amy Welch, Guodong Liu, Doug Leslie, Thomas McGarrity, Thomas Riley. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic SyndromeThe American Journal of Medicine 2017; 130(6): 746.e1 doi: 10.1016/j.amjmed.2016.12.029
17
Barbara Schellhaas. Leberkrebs-Diagnose geht auch ohne BiopsieMMW - Fortschritte der Medizin 2018; 160(3): 59 doi: 10.1007/s15006-018-0203-z
18
Liang Feng, Peng Sun, Zhiyu Li, Ming Liu, Shibo Sun. Knockdown of PPP5C Inhibits Growth of Hepatocellular Carcinoma Cells In VitroApplied Biochemistry and Biotechnology 2015; 175(1): 526 doi: 10.1007/s12010-014-1281-8
19
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouseMammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
20
Khanh Nguyen, Kerri Jack, Weijing Sun. Hepatocellular Carcinoma: Past and Future of Molecular Target TherapyDiseases 2015; 4(1): 1 doi: 10.3390/diseases4010001
21
Sim Y. Ong, Amanda J. Nicoll, Martin B. Delatycki. How should hyperferritinaemia be investigated and managed?European Journal of Internal Medicine 2016; 33: 21 doi: 10.1016/j.ejim.2016.05.014
22
Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular CarcinomaFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00762
23
Kerstin Schütte, Christian Schulz, Janine Poranzke, Kai Antweiler, Jan Bornschein, Tina Bretschneider, Jörg Arend, Jens Ricke, Peter Malfertheiner. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liverBMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-117
24
Richard S. Hoehn, Dennis J. Hanseman, Koffi Wima, Audrey E. Ertel, Ian M. Paquette, Daniel E. Abbott, Shimul A. Shah. Does race affect management and survival in hepatocellular carcinoma in the United States?Surgery 2015; 158(5): 1244 doi: 10.1016/j.surg.2015.03.026
25
Marcus Grohmann, Florian Wiede, Garron T. Dodd, Esteban N. Gurzov, Geraldine J. Ooi, Tariq Butt, Aliki A. Rasmiena, Supreet Kaur, Twishi Gulati, Pei K. Goh, Aislinn E. Treloar, Stuart Archer, Wendy A. Brown, Mathias Muller, Matthew J. Watt, Osamu Ohara, Catriona A. McLean, Tony Tiganis. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCCCell 2018; 175(5): 1289 doi: 10.1016/j.cell.2018.09.053
26
Guang-Ping Qiu, Jie Liu. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular CarcinomaGenetic Testing and Molecular Biomarkers 2016; 20(10): 579 doi: 10.1089/gtmb.2016.0073
27
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and CancerRecent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
28
Barbara Schellhaas, Deike Strobel, Miriam Stumpf, Marion Ganslmayer, Lukas Pfeifer, Ruediger S. Goertz, Markus F. Neurath, Steffen Zopf. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohortsEuropean Journal of Gastroenterology & Hepatology 2018; 30(12): 1422 doi: 10.1097/MEG.0000000000001221
29
Michael C. Kew. Obesity as a cause of hepatocellular carcinomaAnnals of Hepatology 2015; 14(3): 299 doi: 10.1016/S1665-2681(19)31267-0
30
Clifford G. Tepper, Julie H. T. Dang, Susan L. Stewart, Dao M. Fang, Kimberly A. Wong, Stephenie Y. Liu, Ryan R. Davis, Doan Y. Dao, Jeffrey P. Gregg, Natalie J. Török, Moon S. Chen. High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver diseaseCancer 2018; 124: 1583 doi: 10.1002/cncr.31122
31
Weihao Chen, Yurong Wang, Qiuer Liang, Yunfei Cai, Xudong Chen, Yun Zhang, Ruixue Chen, Ya Xiao, Liguo Chen. Efficacy and Safety of Aidi Injection Combined with Transcatheter Arterial Chemoembolization on Primary Hepatic Carcinoma: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/6376429
32
Pia Edenvik, Loa Davidsdottir, Antti Oksanen, Bengt Isaksson, Rolf Hultcrantz, Per Stål. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?Liver International 2015; 35(7): 1862 doi: 10.1111/liv.12764
33
Richard S. Hoehn, Dennis J. Hanseman, Vikrom K. Dhar, Derek E. Go, Michael J. Edwards, Shimul A. Shah. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient PopulationsJournal of the American College of Surgeons 2017; 224(4): 697 doi: 10.1016/j.jamcollsurg.2016.12.023
34
Nishika Sahini, Jürgen Borlak. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytesProgress in Lipid Research 2014; 54: 86 doi: 10.1016/j.plipres.2014.02.002
35
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
36
Manuele Gori, Barbara Barbaro, Mario Arciello, Roberta Maggio, Carmela Viscomi, Alessia Longo, Clara Balsano. Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News?Journal of Cellular Physiology 2014; 229(9): 1182 doi: 10.1002/jcp.24550
37
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
38
Paul Nderitu, Cecilia Bosco, Hans Garmo, Lars Holmberg, Håkan Malmström, Niklas Hammar, Göran Walldius, Ingmar Jungner, Paul Ross, Mieke Van Hemelrijck. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohortInternational Journal of Cancer 2017; 141(6): 1148 doi: 10.1002/ijc.30818
39
Marie Liebig, Alireza Hassanzada, Malte Kämmerling, Berit Genz, Brigitte Vollmar, Kerstin Abshagen. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumorsExperimental Biology and Medicine 2018; 243(1): 1 doi: 10.1177/1535370217738730
40
Iole Ferrara-Romeo, Paula Martínez, Maria A. Blasco, Arthur J. Lustig. Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female micePLOS ONE 2018; 13(10): e0204909 doi: 10.1371/journal.pone.0204909
41
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factorsWorld Journal of Gastroenterology 2014; 20(36): 12945-12955 doi: 10.3748/wjg.v20.i36.12945
42
Manuele Gori, Mario Arciello, Clara Balsano. MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to HepatocarcinomaBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/741465
43
Gaspard d'Assignies, Cindy Fayard, Helena Leitao, Toni Alfaiate, Florence Tubach, Safi Dokmak, Valérie Paradis, Bernard E. Van Beers, Maxime Ronot, Valérie Vilgrain. Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resectionSurgery 2016; 159(4): 1050 doi: 10.1016/j.surg.2015.10.008
44
Alban Zarzavadjian Le Bian, Christine Denet, Nicolas Tabchouri, Gianfranco Donatelli, Philippe Wind, Christophe Louvet, Mostefa Bennamoun, Christos Christidis, Thierry Perniceni, David Fuks, Brice Gayet. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patientsLangenbeck's Archives of Surgery 2018; 403(4): 443 doi: 10.1007/s00423-018-1677-y